rs3819025

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002190.3(IL17A):​c.27+18G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0736 in 1,612,372 control chromosomes in the GnomAD database, including 9,286 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.089 ( 1118 hom., cov: 33)
Exomes 𝑓: 0.072 ( 8168 hom. )

Consequence

IL17A
NM_002190.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.868

Publications

78 publications found
Variant links:
Genes affected
IL17A (HGNC:5981): (interleukin 17A) This gene is a member of the IL-17 receptor family which includes five members (IL-17RA-E) and the encoded protein is a proinflammatory cytokine produced by activated T cells. IL-17A-mediated downstream pathways induce the production of inflammatory molecules, chemokines, antimicrobial peptides, and remodeling proteins. The encoded protein elicits crucial impacts on host defense, cell trafficking, immune modulation, and tissue repair, with a key role in the induction of innate immune defenses. This cytokine stimulates non-hematopoietic cells and promotes chemokine production thereby attracting myeloid cells to inflammatory sites. This cytokine also regulates the activities of NF-kappaB and mitogen-activated protein kinases and can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO). IL-17A plays a pivotal role in various infectious diseases, inflammatory and autoimmune disorders, and cancer. High levels of this cytokine are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis. The lung damage induced by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is to a large extent, a result of the inflammatory response promoted by cytokines such as IL17A. [provided by RefSeq, Sep 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 6-52186476-G-A is Benign according to our data. Variant chr6-52186476-G-A is described in ClinVar as Benign. ClinVar VariationId is 1273159.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.279 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL17ANM_002190.3 linkc.27+18G>A intron_variant Intron 1 of 2 ENST00000648244.1 NP_002181.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL17AENST00000648244.1 linkc.27+18G>A intron_variant Intron 1 of 2 NM_002190.3 ENSP00000497968.1

Frequencies

GnomAD3 genomes
AF:
0.0889
AC:
13520
AN:
152154
Hom.:
1105
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0752
Gnomad AMI
AF:
0.0570
Gnomad AMR
AF:
0.285
Gnomad ASJ
AF:
0.0519
Gnomad EAS
AF:
0.196
Gnomad SAS
AF:
0.177
Gnomad FIN
AF:
0.0288
Gnomad MID
AF:
0.108
Gnomad NFE
AF:
0.0503
Gnomad OTH
AF:
0.0903
GnomAD2 exomes
AF:
0.128
AC:
32108
AN:
250576
AF XY:
0.117
show subpopulations
Gnomad AFR exome
AF:
0.0741
Gnomad AMR exome
AF:
0.431
Gnomad ASJ exome
AF:
0.0533
Gnomad EAS exome
AF:
0.195
Gnomad FIN exome
AF:
0.0286
Gnomad NFE exome
AF:
0.0516
Gnomad OTH exome
AF:
0.113
GnomAD4 exome
AF:
0.0720
AC:
105093
AN:
1460100
Hom.:
8168
Cov.:
30
AF XY:
0.0730
AC XY:
53021
AN XY:
726376
show subpopulations
African (AFR)
AF:
0.0733
AC:
2450
AN:
33440
American (AMR)
AF:
0.414
AC:
18468
AN:
44646
Ashkenazi Jewish (ASJ)
AF:
0.0574
AC:
1499
AN:
26118
East Asian (EAS)
AF:
0.218
AC:
8620
AN:
39586
South Asian (SAS)
AF:
0.156
AC:
13456
AN:
86096
European-Finnish (FIN)
AF:
0.0296
AC:
1583
AN:
53394
Middle Eastern (MID)
AF:
0.101
AC:
582
AN:
5764
European-Non Finnish (NFE)
AF:
0.0483
AC:
53688
AN:
1110724
Other (OTH)
AF:
0.0787
AC:
4747
AN:
60332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
3974
7948
11921
15895
19869
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2362
4724
7086
9448
11810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0890
AC:
13558
AN:
152272
Hom.:
1118
Cov.:
33
AF XY:
0.0936
AC XY:
6968
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.0751
AC:
3122
AN:
41560
American (AMR)
AF:
0.286
AC:
4366
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.0519
AC:
180
AN:
3468
East Asian (EAS)
AF:
0.196
AC:
1016
AN:
5174
South Asian (SAS)
AF:
0.176
AC:
851
AN:
4822
European-Finnish (FIN)
AF:
0.0288
AC:
306
AN:
10614
Middle Eastern (MID)
AF:
0.116
AC:
34
AN:
294
European-Non Finnish (NFE)
AF:
0.0503
AC:
3425
AN:
68036
Other (OTH)
AF:
0.0974
AC:
206
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
535
1070
1605
2140
2675
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
150
300
450
600
750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0723
Hom.:
1662
Bravo
AF:
0.107
Asia WGS
AF:
0.215
AC:
748
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 59% of patients studied by a panel of primary immunodeficiencies. Number of patients: 56. Only high quality variants are reported. -

not provided Benign:1
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.91
DANN
Benign
0.76
PhyloP100
-0.87
PromoterAI
-0.019
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3819025; hg19: chr6-52051274; COSMIC: COSV60684508; API